{"id":20646,"date":"2021-08-19T09:00:24","date_gmt":"2021-08-19T08:00:24","guid":{"rendered":"http:\/\/bitcoinprbuzz.com\/?p=20646"},"modified":"2021-08-19T09:00:24","modified_gmt":"2021-08-19T08:00:24","slug":"molecule-partners-with-vitadao-and-nevermined-creating-first-ever-biopharma-ip-to-nft-transfer-for-longevity-research","status":"publish","type":"post","link":"https:\/\/wire.bitcoinprbuzz.com\/molecule-partners-with-vitadao-and-nevermined-creating-first-ever-biopharma-ip-to-nft-transfer-for-longevity-research\/","title":{"rendered":"Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research"},"content":{"rendered":"

Press Release<\/b>: <\/span>Molecule, a decentralized biopharma marketplace, has developed a novel IP-to-NFT framework with Web3 technology innovator Nevermined. In a historic transaction, the first biopharma IPNFT was successfully transferred to research collective VitaDAO to fund novel longevity therapeutics at the University of Copenhagen.<\/span><\/i><\/p>\n

 <\/p>\n

19th August 2021, Basel, Switzerland \u2014 <\/b>For the first time in history, NFTs are being used for a transfer of IP ownership in medical research. This unique milestone is a result of a partnership between biopharma IP marketplace <\/span>Molecule<\/span><\/a>, and <\/span>VitaDAO<\/span><\/a>, a decentralized collective (DAO) funding longevity research, and the University of Copenhagen. This innovation is enabled by a groundbreaking data storage solution developed by web3 technology innovator <\/span>Nevermined<\/span><\/a>.<\/span><\/p>\n

 <\/p>\n

VitaDAO, Nevermined, and Molecule Overcome Biopharma Industry Challenges\u00a0<\/b><\/span><\/h2>\n

Early-stage biopharma research is the lifeblood that fuels advances in medicine. However, many domains in biopharma suffer from chronic underfunding or commercialization challenges that prevent innovation from reaching patients. Legal complexity, illiquidity of IP assets, and lack of access to investors contribute to the problem for researchers.\u00a0<\/span><\/p>\n

 <\/p>\n

By applying Web3 technology, <\/span>Molecule<\/span><\/a> is enabling a world where researchers get access to an open marketplace that makes novel research and IP discoverable, universally fundable, and distributes ownership. <\/span>Nevermined<\/span><\/a>\u2019s data storage and access control frameworks create entirely new ways of how the data rights surrounding this IP can be transacted with and accessed.<\/span><\/p>\n

 <\/p>\n

VitaDAO recently became the first benefactor of this advancement. The collective used Molecule\u2019s protocol and IP NFT framework to acquire IP resulting from longevity research run at the Danish Scheibye-Knudsen Lab and transferred ownership to VitaDAO.<\/span><\/p>\n

Molecule CEO Paul Kohlhaas<\/b> stated:\u00a0<\/span><\/p>\n

 <\/p>\n

\u201cThis NFT transfer marks a historic milestone for both the NFT and biopharma space. It’s the first time real-world pharma IP is transacted on a blockchain, while also moving into the custodianship of a DAO.\u201d<\/span><\/i><\/p><\/blockquote>\n

 <\/p>\n

Combining Legal Frameworks with Web3 Interoperability<\/b><\/span><\/h2>\n

The early-stage research phase is plagued by a phenomenon coined the Valley of Death – where funding is hard to obtain, meaning many promising discoveries never make it to market. Molecule is building a marketplace for biopharma IP.\u00a0<\/span><\/p>\n

 <\/p>\n

A specialized technical framework combines legal agreements such as IP licenses with the novel technology of NFTs and decentralized secure data storage networks that are coupled with the NFT. By ledgering ownership rights on Ethereum, <\/span>Molecule<\/span><\/a> is building a marketplace for liquid biopharma research data and IP via NFTs. Researchers and biotechs list their projects and discoveries, receive funding via DeFi, and can connect directly with patients. Paul Kohlhaas added:<\/span><\/p>\n

 <\/p>\n

“IP NFTs could effectively replace patent models and become new value drivers thanks to <\/span><\/i>Nevermined<\/span><\/i><\/a>\u2019s data storage frameworks. We hope to enable a myriad of use cases like this, first focusing on longevity and mental health and then broadly becoming a sort of \u201cOpenSea\u201d for Biotech NFTs that helps empower new research organizations like VitaDAO.\u201d\u00a0<\/span><\/i><\/p><\/blockquote>\n

 <\/p>\n

Simultaneously, new vehicles to collaborate and fund research are forming in the web3 space. VitaDAO is a \u201cDecentralised Autonomous Organisation\u201d that collectively funds early longevity research projects via its community contributors. In June 2021, it raised $5 million from hundreds of individuals via a Gnosis batch auction – placing the organization directly into the hands of its community. Now it is on a mission to finance the most promising longevity research endeavors and decentralize their ownership.<\/span><\/p>\n

 <\/p>\n

Want to Live Forever? There\u2019s an NFT for That<\/b><\/span><\/h2>\n

The complex requirements for storing, transferring, and accessing IP-related files require more than just a standard NFT. <\/span>Nevermined<\/span><\/a> implemented its Access Control module to create NFTs on steroids with Molecule. These novel NFTs enable the transacting parties to engage with the underlying protected research data via federated access control. This use case has a wide range of applications in the pharmaceutical industry.<\/span><\/p>\n

 <\/p>\n

\u00a0Nevermind CTO Aitor Argom\u00e1niz<\/b> stated:\u00a0<\/span><\/p>\n

 <\/p>\n

\u201cAccess Control allows creators and owners of digital assets to attach conditions to an NFT. Think of things like pricing, verified users, privacy parameters, etc.. At the same time, it acts as a Gateway to guarantee that only parties that fulfill certain conditions can get access to the underlying documents.\u201d<\/span><\/i><\/p><\/blockquote>\n

 <\/p>\n

The module is also cross-tech-compatible. This allows apps to make secure, critical connections between Ethereum, the cloud (e.g AWS), and decentralized hosting (e.g Arweave). This is the only way to guarantee a Certificate of Authenticity with permanence, traceability, and privacy built-in.<\/span><\/p>\n

 <\/p>\n

Nevermined Socials\u00a0<\/b><\/p>\n

Medium<\/span><\/a> | <\/span>Discord<\/span><\/a> | <\/span>Twitter<\/span><\/a>\u00a0<\/span><\/p>\n

 <\/p>\n

Molecule<\/b> Socials\u00a0<\/b><\/p>\n

Medium<\/span><\/a> | <\/span>Telegram<\/span><\/a> | <\/span>Twitter<\/span><\/a>\u00a0 | <\/span>Discord<\/span><\/a><\/p>\n

 <\/p>\n

VitaDao<\/b> Socials\u00a0<\/b><\/p>\n

Medium<\/span><\/a> | <\/span>Telegram<\/span><\/a> | <\/span>Twitter<\/span><\/a>\u00a0 | <\/span>Discord<\/span><\/a><\/p>\n

 <\/p>\n

Media Contact Details<\/b><\/p>\n

Contact Name: <\/b>Oana Ionescu<\/p>\n

Contact Email: <\/b>\u00a0oana@keyko.io<\/span><\/p>\n

 <\/p>\n

Molecule is the source of this content. This Press Release is for informational purposes only. The information does not constitute investment advice or an offer to invest.\u00a0<\/span><\/i><\/p>\n\n\n","protected":false},"excerpt":{"rendered":"

Press Release: Molecule, a decentralized biopharma marketplace, has developed a novel IP-to-NFT framework with Web3 technology innovator Nevermined. In a historic transaction, the first biopharma IPNFT was successfully transferred to research collective VitaDAO to fund novel longevity therapeutics at the University of Copenhagen.   19th August 2021, Basel, Switzerland \u2014 For the first time in […]<\/p>\n","protected":false},"author":2,"featured_media":20647,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_eb_attr":"","_jf_save_progress":"","_jet_sm_ready_style":"","_jet_sm_style":"","_jet_sm_controls_values":"","_jet_sm_fonts_collection":"","_jet_sm_fonts_links":""},"categories":[1832],"tags":[1857,1854,1855,1856],"yoast_head":"\nMolecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research - Bitcoin PR Buzz<\/title>\n<meta name=\"description\" content=\"Bitcoin PR Buzz - Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/wire.bitcoinprbuzz.com\/molecule-partners-with-vitadao-and-nevermined-creating-first-ever-biopharma-ip-to-nft-transfer-for-longevity-research\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research - Bitcoin PR Buzz\" \/>\n<meta property=\"og:description\" content=\"Bitcoin PR Buzz - Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research\" \/>\n<meta property=\"og:url\" content=\"https:\/\/wire.bitcoinprbuzz.com\/molecule-partners-with-vitadao-and-nevermined-creating-first-ever-biopharma-ip-to-nft-transfer-for-longevity-research\/\" \/>\n<meta property=\"og:site_name\" content=\"Bitcoin PR Buzz\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/BitcoinPRBuzz\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-19T08:00:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i0.wp.com\/wire.bitcoinprbuzz.com\/wp-content\/uploads\/2021\/08\/Molecule-v2.png?fit=1280%2C720&ssl=1\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Bitcoin PR Buzz Feed\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@BitcoinPRBuzz\" \/>\n<meta name=\"twitter:site\" content=\"@BitcoinPRBuzz\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Bitcoin PR Buzz Feed\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/wire.bitcoinprbuzz.com\/molecule-partners-with-vitadao-and-nevermined-creating-first-ever-biopharma-ip-to-nft-transfer-for-longevity-research\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/wire.bitcoinprbuzz.com\/molecule-partners-with-vitadao-and-nevermined-creating-first-ever-biopharma-ip-to-nft-transfer-for-longevity-research\/\"},\"author\":{\"name\":\"Bitcoin PR Buzz Feed\",\"@id\":\"https:\/\/wire.bitcoinprbuzz.com\/#\/schema\/person\/04ff4ec10c935f74958a813a61d640a3\"},\"headline\":\"Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research\",\"datePublished\":\"2021-08-19T08:00:24+00:00\",\"dateModified\":\"2021-08-19T08:00:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/wire.bitcoinprbuzz.com\/molecule-partners-with-vitadao-and-nevermined-creating-first-ever-biopharma-ip-to-nft-transfer-for-longevity-research\/\"},\"wordCount\":801,\"publisher\":{\"@id\":\"https:\/\/wire.bitcoinprbuzz.com\/#organization\"},\"keywords\":[\"Biopharma\",\"Molecule\",\"Nevermined\",\"VitDAO\"],\"articleSection\":[\"Supernova Press Release\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/wire.bitcoinprbuzz.com\/molecule-partners-with-vitadao-and-nevermined-creating-first-ever-biopharma-ip-to-nft-transfer-for-longevity-research\/\",\"url\":\"https:\/\/wire.bitcoinprbuzz.com\/molecule-partners-with-vitadao-and-nevermined-creating-first-ever-biopharma-ip-to-nft-transfer-for-longevity-research\/\",\"name\":\"Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research - Bitcoin PR Buzz\",\"isPartOf\":{\"@id\":\"https:\/\/wire.bitcoinprbuzz.com\/#website\"},\"datePublished\":\"2021-08-19T08:00:24+00:00\",\"dateModified\":\"2021-08-19T08:00:24+00:00\",\"description\":\"Bitcoin PR Buzz - Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research\",\"breadcrumb\":{\"@id\":\"https:\/\/wire.bitcoinprbuzz.com\/molecule-partners-with-vitadao-and-nevermined-creating-first-ever-biopharma-ip-to-nft-transfer-for-longevity-research\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/wire.bitcoinprbuzz.com\/molecule-partners-with-vitadao-and-nevermined-creating-first-ever-biopharma-ip-to-nft-transfer-for-longevity-research\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/wire.bitcoinprbuzz.com\/molecule-partners-with-vitadao-and-nevermined-creating-first-ever-biopharma-ip-to-nft-transfer-for-longevity-research\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/wire.bitcoinprbuzz.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/wire.bitcoinprbuzz.com\/#website\",\"url\":\"https:\/\/wire.bitcoinprbuzz.com\/\",\"name\":\"Bitcoin PR Buzz\",\"description\":\"The Original Bitcoin PR Agency - Bitcoin PR Buzz | Since 2012\",\"publisher\":{\"@id\":\"https:\/\/wire.bitcoinprbuzz.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/wire.bitcoinprbuzz.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/wire.bitcoinprbuzz.com\/#organization\",\"name\":\"Bitcoin PR Buzz - Press Releases\",\"url\":\"https:\/\/wire.bitcoinprbuzz.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/wire.bitcoinprbuzz.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bitcoinprbuzz.com\/wp-content\/uploads\/2019\/03\/BPRB-LOGO-NEW-2.png\",\"contentUrl\":\"https:\/\/bitcoinprbuzz.com\/wp-content\/uploads\/2019\/03\/BPRB-LOGO-NEW-2.png\",\"width\":1024,\"height\":206,\"caption\":\"Bitcoin PR Buzz - Press Releases\"},\"image\":{\"@id\":\"https:\/\/wire.bitcoinprbuzz.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/BitcoinPRBuzz\/\",\"https:\/\/twitter.com\/BitcoinPRBuzz\",\"https:\/\/in.pinterest.com\/bitcoinprbuzz\/bitcoin-press-releases\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/wire.bitcoinprbuzz.com\/#\/schema\/person\/04ff4ec10c935f74958a813a61d640a3\",\"name\":\"Bitcoin PR Buzz Feed\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/wire.bitcoinprbuzz.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7bed372406a02d3f26bcde7d5e2c40dc?s=96&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7bed372406a02d3f26bcde7d5e2c40dc?s=96&r=g\",\"caption\":\"Bitcoin PR Buzz Feed\"},\"description\":\"The World's First Crypto PR Newswire. Founded during Bitcoin\u2019s infancy by original Bitcoin enthusiasts, Bitcoin PR Buzz has over 9 years\u2019 experience in Bitcoin PR and crypto PR distribution. We are the original Bitcoin PR agency, and the oldest crypto newswire in the blockchain sector.\",\"sameAs\":[\"https:\/\/bitcoinprbuzz.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research - Bitcoin PR Buzz","description":"Bitcoin PR Buzz - Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/wire.bitcoinprbuzz.com\/molecule-partners-with-vitadao-and-nevermined-creating-first-ever-biopharma-ip-to-nft-transfer-for-longevity-research\/","og_locale":"en_US","og_type":"article","og_title":"Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research - Bitcoin PR Buzz","og_description":"Bitcoin PR Buzz - Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research","og_url":"https:\/\/wire.bitcoinprbuzz.com\/molecule-partners-with-vitadao-and-nevermined-creating-first-ever-biopharma-ip-to-nft-transfer-for-longevity-research\/","og_site_name":"Bitcoin PR Buzz","article_publisher":"https:\/\/www.facebook.com\/BitcoinPRBuzz\/","article_published_time":"2021-08-19T08:00:24+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/i0.wp.com\/wire.bitcoinprbuzz.com\/wp-content\/uploads\/2021\/08\/Molecule-v2.png?fit=1280%2C720&ssl=1","type":"image\/png"}],"author":"Bitcoin PR Buzz Feed","twitter_card":"summary_large_image","twitter_creator":"@BitcoinPRBuzz","twitter_site":"@BitcoinPRBuzz","twitter_misc":{"Written by":"Bitcoin PR Buzz Feed","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/wire.bitcoinprbuzz.com\/molecule-partners-with-vitadao-and-nevermined-creating-first-ever-biopharma-ip-to-nft-transfer-for-longevity-research\/#article","isPartOf":{"@id":"https:\/\/wire.bitcoinprbuzz.com\/molecule-partners-with-vitadao-and-nevermined-creating-first-ever-biopharma-ip-to-nft-transfer-for-longevity-research\/"},"author":{"name":"Bitcoin PR Buzz Feed","@id":"https:\/\/wire.bitcoinprbuzz.com\/#\/schema\/person\/04ff4ec10c935f74958a813a61d640a3"},"headline":"Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research","datePublished":"2021-08-19T08:00:24+00:00","dateModified":"2021-08-19T08:00:24+00:00","mainEntityOfPage":{"@id":"https:\/\/wire.bitcoinprbuzz.com\/molecule-partners-with-vitadao-and-nevermined-creating-first-ever-biopharma-ip-to-nft-transfer-for-longevity-research\/"},"wordCount":801,"publisher":{"@id":"https:\/\/wire.bitcoinprbuzz.com\/#organization"},"keywords":["Biopharma","Molecule","Nevermined","VitDAO"],"articleSection":["Supernova Press Release"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/wire.bitcoinprbuzz.com\/molecule-partners-with-vitadao-and-nevermined-creating-first-ever-biopharma-ip-to-nft-transfer-for-longevity-research\/","url":"https:\/\/wire.bitcoinprbuzz.com\/molecule-partners-with-vitadao-and-nevermined-creating-first-ever-biopharma-ip-to-nft-transfer-for-longevity-research\/","name":"Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research - Bitcoin PR Buzz","isPartOf":{"@id":"https:\/\/wire.bitcoinprbuzz.com\/#website"},"datePublished":"2021-08-19T08:00:24+00:00","dateModified":"2021-08-19T08:00:24+00:00","description":"Bitcoin PR Buzz - Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research","breadcrumb":{"@id":"https:\/\/wire.bitcoinprbuzz.com\/molecule-partners-with-vitadao-and-nevermined-creating-first-ever-biopharma-ip-to-nft-transfer-for-longevity-research\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/wire.bitcoinprbuzz.com\/molecule-partners-with-vitadao-and-nevermined-creating-first-ever-biopharma-ip-to-nft-transfer-for-longevity-research\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/wire.bitcoinprbuzz.com\/molecule-partners-with-vitadao-and-nevermined-creating-first-ever-biopharma-ip-to-nft-transfer-for-longevity-research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/wire.bitcoinprbuzz.com\/"},{"@type":"ListItem","position":2,"name":"Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research"}]},{"@type":"WebSite","@id":"https:\/\/wire.bitcoinprbuzz.com\/#website","url":"https:\/\/wire.bitcoinprbuzz.com\/","name":"Bitcoin PR Buzz","description":"The Original Bitcoin PR Agency - Bitcoin PR Buzz | Since 2012","publisher":{"@id":"https:\/\/wire.bitcoinprbuzz.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/wire.bitcoinprbuzz.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/wire.bitcoinprbuzz.com\/#organization","name":"Bitcoin PR Buzz - Press Releases","url":"https:\/\/wire.bitcoinprbuzz.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/wire.bitcoinprbuzz.com\/#\/schema\/logo\/image\/","url":"https:\/\/bitcoinprbuzz.com\/wp-content\/uploads\/2019\/03\/BPRB-LOGO-NEW-2.png","contentUrl":"https:\/\/bitcoinprbuzz.com\/wp-content\/uploads\/2019\/03\/BPRB-LOGO-NEW-2.png","width":1024,"height":206,"caption":"Bitcoin PR Buzz - Press Releases"},"image":{"@id":"https:\/\/wire.bitcoinprbuzz.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/BitcoinPRBuzz\/","https:\/\/twitter.com\/BitcoinPRBuzz","https:\/\/in.pinterest.com\/bitcoinprbuzz\/bitcoin-press-releases\/"]},{"@type":"Person","@id":"https:\/\/wire.bitcoinprbuzz.com\/#\/schema\/person\/04ff4ec10c935f74958a813a61d640a3","name":"Bitcoin PR Buzz Feed","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/wire.bitcoinprbuzz.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7bed372406a02d3f26bcde7d5e2c40dc?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7bed372406a02d3f26bcde7d5e2c40dc?s=96&r=g","caption":"Bitcoin PR Buzz Feed"},"description":"The World's First Crypto PR Newswire. Founded during Bitcoin\u2019s infancy by original Bitcoin enthusiasts, Bitcoin PR Buzz has over 9 years\u2019 experience in Bitcoin PR and crypto PR distribution. We are the original Bitcoin PR agency, and the oldest crypto newswire in the blockchain sector.","sameAs":["https:\/\/bitcoinprbuzz.com"]}]}},"jetpack_featured_media_url":"https:\/\/i0.wp.com\/wire.bitcoinprbuzz.com\/wp-content\/uploads\/2021\/08\/Molecule-v2.png?fit=1280%2C720&ssl=1","distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"Bitcoin PR Buzz","distributor_original_site_url":"https:\/\/wire.bitcoinprbuzz.com","push-errors":false,"_links":{"self":[{"href":"https:\/\/wire.bitcoinprbuzz.com\/wp-json\/wp\/v2\/posts\/20646"}],"collection":[{"href":"https:\/\/wire.bitcoinprbuzz.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wire.bitcoinprbuzz.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wire.bitcoinprbuzz.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/wire.bitcoinprbuzz.com\/wp-json\/wp\/v2\/comments?post=20646"}],"version-history":[{"count":2,"href":"https:\/\/wire.bitcoinprbuzz.com\/wp-json\/wp\/v2\/posts\/20646\/revisions"}],"predecessor-version":[{"id":20649,"href":"https:\/\/wire.bitcoinprbuzz.com\/wp-json\/wp\/v2\/posts\/20646\/revisions\/20649"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wire.bitcoinprbuzz.com\/wp-json\/wp\/v2\/media\/20647"}],"wp:attachment":[{"href":"https:\/\/wire.bitcoinprbuzz.com\/wp-json\/wp\/v2\/media?parent=20646"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wire.bitcoinprbuzz.com\/wp-json\/wp\/v2\/categories?post=20646"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wire.bitcoinprbuzz.com\/wp-json\/wp\/v2\/tags?post=20646"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}